Questions abound over the impact that health reform and related measures will have on patients’ ability to receive the medications they want and need. In this podcast, we discuss what pharmaceutical manufacturers, payers, providers, and patients are doing in response to this dynamic healthcare environment. Specifically, our speaker will examine:

• How health reform might affect quality of care and what preparations are being made by stakeholders such as manufacturers and payers
• Immediate and potential long-term impact of biosimilars in the specialty space
• Use of patient adherence and patient assistance programs as a way to promote proper therapy utilization
• The current and future state of hot button issues like comparative effectiveness and REMS

< View more webcasts, podcasts, and webisodes